To study effectiveness of Daruharidra ghana vati compare to arogyavardhini vati in karnasrava.

Comparative Clinical Study of efficacy of Daruharidra Ghana Vati and Arogyavardhini Vati In the Treatment Of Karnasrava

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020107

Enrollment

Registered

2019-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H650- Acute serous otitis media

Interventions

Intervention1: Daruharidra Ghana Vati : Orally 500 mg with luke warm water twice daily for 15 days Follow up on 5th 10th and 15th day for age grp 18 to 60 yr Control Intervention1: Arogya vardhini vat

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sings and symptoms of karnasrava vyadhi Tubotympanic disease Patients willing for trials

Exclusion criteria

Exclusion criteria: Atticoantral disease Csf otorrhoea Patients not willing for trials

Design outcomes

Primary

Measure	Time frame
Efficacy of Daruharidra Ghana Vati and Arogya vardhini vati in the treatment of karnasravaTimepoint: 15 days	—

Secondary

Measure	Time frame
To observe side effects of Daruharidra Ghana VatiTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Mangesh Nandkishor Hegge

Tilak Ayurved Mahavidyalay pune

salvisangeeta@yahoo.co.in9822082795

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026